Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout Â
Shionogi's acquisition of IntraBio would expand its rare disease portfolio following the recent acquisition of ALS drug, Radicava.
Read Full Article
Pharma Tech
Lilly deepens ties with Gate Bioscience in $870m deal expansionÂ
Lilly is continuing to bet on the molecular gate approach, which Gate says could create therapies targeting hard-to-drug proteins.
Read Full Article
Pharma Tech
Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal
Alector’s approach combines an engineered GCase with the biotech’s blood-brain barrier delivery platform.
Read Full Article
Pharma Tech
CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug Â
CSL and Alentis will work together to progress antifibrotic drug, lixudebart across multiple rare kidney and liver diseases.
Read Full Article
Pharma Tech
Pacira partners with Molteni for Exparel commercialisation
Pacira BioSciences has entered into an exclusive agreement with Italian pharmaceutical company Molteni Farmaceutici to distribute and commercialise Exparel across the EU and the UK.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 6, 2026, 2:02 PM
Eris Life names Chirag Mehta as Executive Director
Mehta will oversee international business, finance and investor relations and will report to the CMD.
ET Pharma
Oct 6, 2026, 1:42 PM
Aragen Life deploys new platform for ADC, peptides at Nacharam plant
The platform expands capabilities for multiple molecules, including cytotoxic payloads used in oncology, and and adds an active ingredient manufacturing line with an annual capacity of 500–600 kg.
PharmaShots
Oct 6, 2026, 1:30 PM
Key Biosimilars Events of September 2026 Â
Shots:  Cipla Partners with Qilu Pharmaceutical to Commercialize QL2107 (Biosimilar, Keytruda) in the US       Company: Cipla & Qilu Pharmaceutical      Product: QL2107      Active Ingredient:  Pembrolizumab      Reference Product: Keytruda      Reference Product Company: Merck       Disease: All Approved Indications       Date: Sep 03, 2026  Shots: Editor’s Take: Beyond the Headlines Cipla’s entry into the US pembrolizumab biosimilar market could intensify competition around Keytruda, particularly as patent and exclusivity… The post Key Biosimilars Events of September 2026  appeared first on PharmaShots.
PharmaShots
Oct 6, 2026, 12:30 PM
Kairos Pharma Reports Positive Interim P-II Data for ENV-105 in Metastatic Prostate Cancer
Shots: Ref:Â Business Wire | Image:Â Kairos Pharma | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com The post Kairos Pharma Reports Positive Interim P-II Data for ENV-105 in Metastatic Prostate Cancer appeared first on PharmaShots.
PharmaShots
Oct 6, 2026, 11:30 AM
Telix Reports First US Patients Dosed with FDA-Approved Pixclara for Glioma Imaging
Shots: Ref:Â Telix | Image:Â Telix | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com The post Telix Reports First US Patients Dosed with FDA-Approved Pixclara for Glioma Imaging appeared first on PharmaShots.
Pharma Tech
Oct 6, 2026, 10:59 AM
Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout Â
Shionogi's acquisition of IntraBio would expand its rare disease portfolio following the recent acquisition of ALS drug, Radicava.
News
Latest industry coverage
Google News
Oct 6, 2026, 8:49 PM
Chinese Makers of Fentanyl Ingredients Now Sell Bootleg Peptides to Americans - WSJ
Chinese Makers of Fentanyl Ingredients Now Sell Bootleg Peptides to Americans  WSJ
Google News
Oct 6, 2026, 8:46 PM
AstraZeneca Opens Strategic R&D Center in Massachusetts - Contract Pharma
AstraZeneca Opens Strategic R&D Center in Massachusetts  Contract Pharma
Google News
Oct 6, 2026, 8:38 PM
French Tax on Evergreening Practices: Uncertainties Remain for Pharma Companies - JDSupra
French Tax on Evergreening Practices: Uncertainties Remain for Pharma Companies  JDSupra
Google News
Oct 6, 2026, 8:17 PM
Global healthcare companies invest billions to boost US presence - Reuters
Global healthcare companies invest billions to boost US presence  Reuters
Google News
Oct 6, 2026, 8:13 PM
Preparing an Internationally Developed Therapy for Late-stage U.S. Trials - Contract Pharma
Preparing an Internationally Developed Therapy for Late-stage U.S. Trials  Contract Pharma
Google News
Oct 6, 2026, 7:35 PM
MFN Raises the Stakes for Japan Launch Pricing - Pharmaceutical Executive
MFN Raises the Stakes for Japan Launch Pricing  Pharmaceutical Executive
Google News
Oct 6, 2026, 7:20 PM
What Supply Chain Resilience Actually Requires in a Volatile Global Market: LogiPharma2026 - Pharmaceutical Executive
What Supply Chain Resilience Actually Requires in a Volatile Global Market: LogiPharma2026Â Â Pharmaceutical Executive
Google News
Oct 6, 2026, 7:16 PM
Winners of the 2026 CPHI Pharma Awards Announced - PharmTech.com
Winners of the 2026 CPHI Pharma Awards Announced  PharmTech.com
Google News
Oct 6, 2026, 7:14 PM
Bayer plans $2.2B pharma manufacturing campus in Ohio - NJBIZ
Bayer plans $2.2B pharma manufacturing campus in Ohio  NJBIZ
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer